Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms

Mostrar otras versiones (1)

In the era of new and mostly effective therapeutic protocols, multiple myeloma still tends to be a hard-to-treat hematologic cancer. This hallmark of the disease is in fact a sequel to drug resistant phenotypes persisting initially or emerging in the course of treatment. Furthermore, the heterogeneo...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdi, Jahangir, Chen, Guoan, Chang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926819/
https://www.ncbi.nlm.nih.gov/pubmed/24327604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926819/
https://www.ncbi.nlm.nih.gov/pubmed/24327604

Ejemplares similares